A Comparison of International Guidelines for Rhinosinusitis

J Allergy Clin Immunol Pract. 2022 Jun;10(6):1418-1422. doi: 10.1016/j.jaip.2022.01.013. Epub 2022 Jan 25.

Abstract

The European Position Paper on Rhinosinusitis and Nasal Polyps (EPOS), latest version EPOS2020, and the International Consensus Statement on Allergy and Rhinology: Rhinosinusitis (ICAR-RS), latest version ICAR-RS-2021, assimilate thousands of articles on the topic of rhinosinusitis. Encompassing scores of subtopics and relying on the perspectives of many international experts, EPOS2020 and ICAR-RS-2021 reduce the existing data into consumable formats and create evidence-based recommendations. The approaches and findings are similar in many respects but have significant differences. This clinical commentary, authored by some of the principal authors of these documents, compares and contrasts EPOS2020 and ICAR-RS-2021, examining methodology, diagnostic and treatment recommendations, and each document's emphases. This commentary demonstrates that, through somewhat differing methodologies, the 2 documents arrive at largely similar conclusions. Those who care for patients suffering from rhinosinusitis will find the documents complementary and valuable in their differences as much as in their similarities.

Keywords: International guidelines; Rhinosinusitis.

MeSH terms

  • Chronic Disease
  • Humans
  • Iron-Dextran Complex
  • Nasal Polyps* / diagnosis
  • Nasal Polyps* / therapy
  • Rhinitis* / diagnosis
  • Rhinitis* / therapy
  • Rhinitis, Allergic* / therapy
  • Sinusitis* / diagnosis
  • Sinusitis* / therapy

Substances

  • Iron-Dextran Complex